author:"Vina, J." | Pollux - Fachinformationsdienst Politikwissenschaft

Open Access#22018

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

Egea, J; Fabregat, I; Frapart, Y. M; Ghezzi, P; Görlach, A; Kietzmann, T; Kubaichuk, K; Knaus, Ulla G

Egea, J; Fabregat, I; Frapart, Y. M; Ghezzi, P; Görlach, A; Kietzmann, T; Kubaichuk, K; Knaus, Ulla G; Lopez, M. G; Olaso-Gonzalez, Gloria; Petry, A; Schulz, R; Vina, J; Winyard, P; Abbas, Kahina; Ademowo, O. S; Afonso, C. B; Andreadou, I; Antelmann, H; Antunes, F; Aslan, M; Bachschmid, M. M; Barbosa, R. M; Belousov, Vsevolod; Berndt, C; Bernlohr, D; Bertrán, E; Bindoli, A; Bottari, S. P; Brito, Paula M; Carrara, G; Casas, A. I; Chatzi, A; Chondrogianni, N; Conrad, M; Cooke, M. S; Costa, J. G; Cuadrado, A; My-Chan Dang, P; De Smet, B; Debelec-Butuner, B; Dias, I. H.K; Dunn, J. D; Edson, A. J; El Assar, M; El-Benna, J; Ferdinandy, P; Fernandes, Ana S; Fladmark, K. E; Förstermann, U; Giniatullin, R; Giricz, Z; Görbe, A; Griffiths, H; Hampl, V; Hanf, A; Herget, J; Hernansanz Agustín, Pablo; Hillion, M; Huang, J; Ilikay, S; Jansen-Dürr, P; Jaquet, V; Joles, J. A; Kalyanaraman, B; Kaminskyy, D; Karbaschi, M; Kleanthous, M; Klotz, L. O; Korac, B; Korkmaz, K. S; Koziel, R; Kračun, D; Krause, K. H; Křen, V; Krieg, T; Laranjinha, J; Lazou, A; Li, H; Martínez-Ruíz, Antonio; Matsui, R; McBean, G. J; Meredith, Stuart P; Messens, J; Miguel, Verónica; Mikhed, Y; Milisav, I; Milković, L; Miranda-Vizuete, A; Mojović, M; Monsalve, M; Mouthuy, P. A; Mulvey, J; Münzel, T; Muzykantov, V; Nguyen, I. T.N; Oelze, M; Oliveira, N. G; Palmeira, C. M; Papaevgeniou, N

The authors regret that they have to correct the acknowledgement of the above mentioned publication as follows: This article/publication is based upon work from COST Action BM1203 (EU-ROS), supported by COST (European Cooperation in Science and Technology) which is funded by the Horizon 2020 Framework Programme of the European Union. COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. For further information see www.cost.eu. The authors would like to apologise for any inconvenience caused. ; This article/publication is based upon work from COST Action BM1203 (EU-ROS), supported by COST (European Cooperation in Science and Technology) which is funded by the Horizon 2020 Framework Programme of the European Union. COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks.

Open Access

Filter

Format

Type

Language

Time Range

Growth Hormone Replacement Therapy Prevents Sarcopenia by a Dual Mechanism: Improvement of Protein Balance and of Antioxidant Defenses

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

Search results

Filter

Format

Type

Language

Time Range

Growth Hormone Replacement Therapy Prevents Sarcopenia by a Dual Mechanism: Improvement of Protein Balance and of Antioxidant Defenses

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))

Contact

Help